Results 21 to 30 of about 18,339 (171)

FXTAS and the Spectrum of FMR1 Premutation‐Associated Phenotypes in Latin America: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Fragile X–associated tremor/ataxia syndrome (FXTAS) is a late‐onset neurodegenerative disorder caused by FMR1 premutation expansions (55–200 CGG repeats). Although well described in populations of predominantly European ancestry, FXTAS remains poorly characterized in Latin America due to limited awareness, restricted access to ...
Amy Schmidmajer, Salomón Páez‐García, Santiago Martínez, Jacobo Ramírez‐Triana, Kevin O'Hara‐Veintimilla, Andrés Ricaurte‐Fajardo, Catalina Cerquera‐Cleves   +6 more
wiley   +1 more source

Resúmenes de los reportes de casos

Medisur, 2010
Los reportes de casos siempre son muy interesantes dado que los autores presentan en general casos muy pocos vistos en la literatura médica o muy poco conocidos.
Congreso Nacional de Neurología
doaj   +2 more sources

Socio‐Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Socio‐occupational functioning in patients with Parkinson's disease (PD) treated with subthalamic nucleus deep brain stimulation (STN‐DBS) is not fully captured by standard motor and quality‐of‐life scales. Objectives To characterize patient‐reported socio‐occupational functioning after STN‐DBS and explore associated clinical and ...
Gabriele Imbalzano, Elisa Montanaro, Martina Giacchero, Claudia Ledda, Alberto Romagnolo, Mario Giorgio Rizzone, Leonardo Lopiano, Maurizio Zibetti   +7 more
wiley   +1 more source

Vagus nerve stimulation may be a sound therapeutic option in the treatment of refractory epilepsy

Arquivos de Neuro-Psiquiatria, 2013
INTRODUCTION: Refractory epilepsy accounts for 20 to 30% of epilepsy cases and remains a challenge for neurologists. Vagus nerve stimulation (VNS) is an option for palliative treatment.
Murilo S. Meneses, Samanta F. B. Rocha, Cristiane Simão, Heraldo Nei Hardt Laroca dos Santos, Cleudi Pereira, Pedro A. Kowacs   +5 more
doaj   +1 more source

Effect of COMT and UGT1A Variants on Clinical Response to Opicapone in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is the second most common neurodegenerative disease. Symptomatic treatment is based on dopaminergic replacement. With disease progression, the initial benefit of levodopa becomes inconsistent, and motor complications emerge.
Elena Ojeda‐Lepe, Sergio García‐Díaz, Laura Muñoz‐Delgado, Miguel Martín‐Bórnez, Silvia Jesús, Dolores Buiza‐Rueda, Marta Bonilla‐Toribio, Rafael Díaz‐Belloso, Daniel Macías‐García, Astrid Adarmes‐Gómez, Antonio Luque‐Ambrosiani, Rocío Pineda‐Sánchez, Lorena Clavijo‐Jiménez, Fátima Carrillo‐García, Pilar Gómez‐Garre, Pablo Mir   +15 more
wiley   +1 more source

Resúmenes de los trabajos sobre enfermedades cerebrovasculares

Medisur, 2010
La enfermedad cererebrovascular constituye un serio problema sociosanitario, actualmente se considera una de las principales causas de muerte en la población adulta, con tendencia creciente en su incidencia y prevalencia en la población cubana de dichas ...
Congreso Nacional de Neurología
doaj   +2 more sources

Natural Killer Subset Changes and Vascular Endothelial Growth Factor‐A Plasma Profile in Progressive Supranuclear Palsy: The NKscape Study

Movement Disorders, EarlyView.
Abstract Background Emerging evidence implicates neuroinflammation in progressive supranuclear palsy (PSP) pathophysiology, with elevated cyto‐chemokines suggesting natural killer (NK) cell involvement. Methods We characterized peripheral NK in PSP (N = 11) versus Parkinson's disease (PD, N = 10) and healthy controls (HC, N = 8) at both ...
Marina Picillo, Cristina Basile, Francesco Montella, Valentina Lopardo, Mariangela Orlando, Roberta Tarallo, Domenico Palumbo, Viola Melone, Maria Francesca Tepedino, Paolo Barone, Annibale Alessandro Puca, Elena Ciaglia   +11 more
wiley   +1 more source

Las primeras sociedades neurológicas catalanas y sus protagonistas

Neurología, 2012
Resumen: Introduction: El conocimiento de las sociedades neurológicas anteriores a la Sociedad Española de Neurología (año 1949) es escaso. Las analizamos partiendo de la pionera Sociedad de Psiquiatría y Neurología de Barcelona, fundada en 1911 ...
A. Arboix, M.G. Fabregas
doaj   +1 more source

Co‐ and Multi‐Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review

Movement Disorders, EarlyView.
Abstract Parkinson's disease (PD) has been historically defined as a disease of striatal dopamine deficiency secondary to degeneration of dopaminergic neurons in the substantia nigra pars compacta, related to the presence of Lewy bodies and Lewy neurites.
Michele Matarazzo, Per Borghammer, Inas Elsayed, Jennifer G. Goldman, Yue Huang, Katja Lohmann, Per Svenningsson, Lorraine V. Kalia, Daniela Berg, Jeffrey H. Kordower, the MDS Scientific Issues Committee   +10 more
wiley   +1 more source

Anais do II Congresso Sul Mineiro de Anatomia Aplicada à Neurologia

Revista Ciências em Saúde, 2020
O II Congresso Sul Mineiro de Anatomia Aplicada à Neurologia foi realizado de maneira gratuita, com o objetivo de levar conhecimentos neuroanatômicos de base no âmbito clínico, cirúrgico, semiológico e radiológico para acadêmicos na área da saúde.
II Congresso Sul Mineiro de Anatomia Aplicada à Neurologia
doaj   +1 more source